Table 1.
Cohort statistics
| Positive for SARS-CoV-2 | Deceased at 28 days* | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No. of patients in database | Percent of database | n | % | n | % | |||||
| Without T2DM | 64,936,797 | 94.2 | 200,293 | 0.3 | 3,209 | 1.6 | ||||
| With T2DM | 4,022,267 | 5.8 | 29,516 | 0.7 | 1,921 | 6.5 | ||||
| Total | 68,959,064 | — | 229,809 | 0.3 | 5,130 | 2.2 | ||||
| Patients with COVID-19 without T2DM | Patients with COVID-19 with T2DM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age, years | Deceased at 28 days, n (%) | Alive at 28 days, n | Total, n | Deceased at 28 days, n (%) | Alive at 28 days, n | Total, n | Fold increase in risk for T2DM | |||
| <30 | 44 (0.07) | 63,162 | 63,206 | 10 (1.59) | 619 | 629 | 22.8 | |||
| 30–40 | 63 (0.17) | 36,252 | 36,315 | 26 (1.49) | 1,715 | 1,741 | 8.6 | |||
| 40–50 | 128 (0.41) | 31,333 | 31,461 | 54 (1.36) | 3,931 | 3,985 | 3.3 | |||
| 50–60 | 272 (0.95) | 28,383 | 28,655 | 231 (3.38) | 6,611 | 6,842 | 3.6 | |||
| 60–70 | 525 (2.65) | 19,260 | 19,785 | 388 (5.28) | 6,954 | 7,342 | 2.0 | |||
| 70–80 | 793 (7.25) | 10,138 | 10,931 | 587 (10.77) | 4,863 | 5,450 | 1.5 | |||
| 80–90 | 959 (13.81) | 5,986 | 6,945 | 496 (17.45) | 2,346 | 2,842 | 1.3 | |||
| >90 | 425 (14.19) | 2,570 | 2,995 | 129 (18.83) | 556 | 685 | 1.3 | |||
| Total | 3,209 (1.60) | 197,084 | 200,293 | 1,921 (6.51) | 27,595 | 29,516 | 4.1 | |||
*
Patients with the term “deceased” in the medical record within 28 days of a diagnosis of COVID-19 or positive test results for SARS-CoV-2 were included in the deceased group, while all others were assigned to the alive group.